SNOA
Sonoma Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
SNOA fundamentals
Sonoma Pharmaceuticals (SNOA) Revenue Breakdown: Q3 2026 Business & Regional Performance
Sonoma Pharmaceuticals (SNOA) reported total revenue of 4.35M USD in Q3 2026, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 28.01% of total revenue. Explore Sonoma Pharmaceuticals's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Sonoma Pharmaceuticals (SNOA) reported total revenue of 4.35M USD in Q3 2026, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 28.01% of total revenue. Explore Sonoma Pharmaceuticals's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
Did Sonoma Pharmaceuticals beat or miss consensus estimates last quarter?What guidance did Sonoma Pharmaceuticals's management provide for the next earnings period?What does Sonoma Pharmaceuticals do and what are its main business segments?What were the key takeaways from Sonoma Pharmaceuticals’s earnings call?What factors drove the changes in Sonoma Pharmaceuticals's revenue and profit?What is the market's earnings forecast for Sonoma Pharmaceuticals next quarter?What is the revenue and EPS growth rate for Sonoma Pharmaceuticals year over year?What is Sonoma Pharmaceuticals's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
